Cochlear (COH:ASX) Annual Reports & Investor Relations Material

Overview

Cochlear Limited is a company that specializes in implantable hearing solutions. Their products include cochlear implant systems, wireless accessories, and bone-anchored facial prosthetic solutions. The Nucleus 6 is one of their cochlear implant systems and they also offer Cochlear Nucleus Aqua+, a silicone sleeve for their processors. The company's wireless accessories include mini microphones, phone clips, and TV streamers. They also have Cochlear Vistafix, a solution for enhancing the attachment and cosmetic outcome of facial prostheses.

Frequently Asked Questions

What is Cochlear's ticker?

Cochlear's ticker is COH

What exchange is Cochlear traded on?

The company's shares trade on the ASX stock exchange

Where are Cochlear's headquarters?

They are based in North Ryde, Australia

How many employees does Cochlear have?

There are 1001-5000 employees working at Cochlear

What is Cochlear's website?

It is cochlear.com/us/en/home

What type of sector is Cochlear?

Cochlear is in the Healthcare sector

What type of industry is Cochlear?

Cochlear is in the Medical Appliances & Equipment industry

Who are Cochlear's peers and competitors?

The following five companies are Cochlear's industry peers:

- IRadimed

- Adaptimmune Therapeutics

- Integer

- STRATA Skin Sciences

- SiNtx Technologies, Inc.